BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND TG, Thyroglobulin AND Prognosis
33 results:

  • 1. Retrospective case-control study examining the relationship between recurrence-free survival and changes in pre- and post-radioiodine therapy serum thyroglobulin levels in patients with differentiated thyroid cancer.
    Watanabe K; Igarashi T; Uchiyama M; Ishigaki T; Ojiri H
    Jpn J Radiol; 2024 Apr; 42(4):391-397. PubMed ID: 38212512
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Potential Role of Zinc Finger 365
    Ghadamgahi SR; Hosseinzadeh L; Ardalan Khales S; Nassiri M; Alidoust M; Etemadrezaei S; Khorshid Shamshiri A; Homaei Shandiz F; Pasdar A; Afzaljavan F
    Iran J Med Sci; 2023 Nov; 48(6):551-562. PubMed ID: 38094285
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Robust Identification of Differential Gene Expression Patterns from Multiple Transcriptomics Datasets for Early Diagnosis, prognosis, and Therapies for breast cancer.
    Tuly KF; Hossen MB; Islam MA; Kibria MK; Alam MS; Harun-Or-Roshid M; Begum AA; Hasan S; Mahumud RA; Mollah MNH
    Medicina (Kaunas); 2023 Sep; 59(10):. PubMed ID: 37893423
    [No Abstract]    [Full Text] [Related]  

  • 4. Multi-omics profiling of papillary thyroid microcarcinoma reveals different somatic mutations and a unique transcriptomic signature.
    Li Q; Feng T; Zhu T; Zhang W; Qian Y; Zhang H; Zheng X; Li D; Yun X; Zhao J; Li Y; Yu H; Gao M; Qian B
    J Transl Med; 2023 Mar; 21(1):206. PubMed ID: 36941725
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Comprehensive prognostic effects of systemic inflammation and Insulin resistance in women with breast cancer with different BMI: a prospective multicenter cohort.
    Ruan GT; Xie HL; Hu CL; Liu CA; Zhang HY; Zhang Q; Wang ZW; Zhang X; Ge YZ; Lin SQ; Tang M; Song MM; Zhang XW; Liu XY; Zhang KP; Yang M; Yu KY; Wang KH; Hu W; Deng L; Cong MH; Shi HP
    Sci Rep; 2023 Mar; 13(1):4303. PubMed ID: 36922570
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. thyroglobulin expression, Ki-67 index, and lymph node ratio in the prognostic assessment of papillary thyroid cancer.
    Lindfors H; Karlsen M; Karlton E; Zedenius J; Larsson C; Ihre Lundgren C; Juhlin CC; Shabo I
    Sci Rep; 2023 Jan; 13(1):1070. PubMed ID: 36658256
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinical verification of the relationship between serum lipid metabolism and immune activity in breast cancer patients treated with neoadjuvant chemotherapy.
    Goto W; Kashiwagi S; Takada K; Asano Y; Ogisawa K; Morisaki T; Shibutani M; Tanaka H; Maeda K
    Eur J Med Res; 2023 Jan; 28(1):2. PubMed ID: 36593486
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Integrated bioinformatics and statistical approaches to explore molecular biomarkers for breast cancer diagnosis, prognosis and therapies.
    Alam MS; Sultana A; Reza MS; Amanullah M; Kabir SR; Mollah MNH
    PLoS One; 2022; 17(5):e0268967. PubMed ID: 35617355
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Efficacy, Safety, and prognosis of Sequential Therapy with Tamoxifen and Letrozole versus Letrozole Monotherapy for breast Carcinoma.
    Lu X; Qian C
    Comput Math Methods Med; 2022; 2022():1979254. PubMed ID: 35464999
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Development of a Prognostic Factor Index Among Women With HR
    Vidal GA; Carter GC; Gilligan AM; Saverno K; Zhu YE; Price GL; DeLuca A; Smyth EN; Rybowski S; Huang YJ; Schwartzberg LS
    Clin Breast Cancer; 2021 Aug; 21(4):317-328.e7. PubMed ID: 33678566
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Discovering novel driver mutations from pan-cancer analysis of mutational and gene expression profiles.
    Tegally H; Kensler KH; Mungloo-Dilmohamud Z; Ghoorah AW; Rebbeck TR; Baichoo S
    PLoS One; 2020; 15(11):e0242780. PubMed ID: 33232371
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. High atherogenic index of plasma and cardiovascular risk factors among Ghanaian breast cancer patients.
    Tagoe EA; Dwamena-Akoto E; Nsaful J; Aikins AR; Clegg-Lamptey JN; Quaye O
    Exp Biol Med (Maywood); 2020 Dec; 245(18):1648-1655. PubMed ID: 32640892
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Thrombin generation predicts early recurrence in breast cancer patients.
    Marchetti M; Giaccherini C; Masci G; Verzeroli C; Russo L; Celio L; Sarmiento R; Gamba S; Tartari CJ; Diani E; Vignoli A; Malighetti P; Spinelli D; Kuderer NM; Nichetti F; Minelli M; Tondini C; Barni S; Giuliani F; Petrelli F; D'Alessio A; Gasparini G; Labianca R; Santoro A; De Braud F; Falanga A;
    J Thromb Haemost; 2020 Sep; 18(9):2220-2231. PubMed ID: 32397009
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Lymphocyte-Monocyte Ratio Significantly Predicts Recurrence in Papillary Thyroid cancer.
    Yokota M; Katoh H; Nishimiya H; Kikuchi M; Kosaka Y; Sengoku N; Watanabe M; Yamashita K
    J Surg Res; 2020 Feb; 246():535-543. PubMed ID: 31711613
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Signet ring cell variant of follicular thyroid carcinoma: Report of two cases with focus on morphological, expressional and genetic characteristics.
    Hysek M; Jatta K; Stenman A; Darai-Ramqvist E; Zedenius J; Höög A; Juhlin CC
    Diagn Pathol; 2019 Nov; 14(1):127. PubMed ID: 31699114
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Development of an ENPP1 Fluorescence Probe for Inhibitor Screening, Cellular Imaging, and Prognostic Assessment of Malignant breast cancer.
    Kawaguchi M; Han X; Hisada T; Nishikawa S; Kano K; Ieda N; Aoki J; Toyama T; Nakagawa H
    J Med Chem; 2019 Oct; 62(20):9254-9269. PubMed ID: 31536342
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Claudin-low-like mouse mammary tumors show distinct transcriptomic patterns uncoupled from genomic drivers.
    Fougner C; Bergholtz H; Kuiper R; Norum JH; Sørlie T
    Breast Cancer Res; 2019 Jul; 21(1):85. PubMed ID: 31366361
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Gastric GIST and prognostic models. Which is the best to predict survival after surgery?
    Di Vita M; Zanghì A; Cavallaro A; Cardì F; Uhlig M; Ursi P; Lo Menzo E; Panebianco V; Cappellani A
    Ann Ital Chir; 2019; 90():31-40. PubMed ID: 30942768
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Association of the
    Miedl H; Lebhard J; Ehart L; Schreiber M
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30691044
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Relationship between resting heart rate and metabolic risk factors in breast cancer patients.
    Lee MK; Lee DH; Park S; Kim SI; Jeon JY
    Clin Chim Acta; 2018 Nov; 486():104-109. PubMed ID: 30030991
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.